Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

HAP1.PRKACA (Subject)

Role Id:

cell line ancestor

Subject Role (Entity type)

Project:

LINCS

Project (Entity type)

Id Namespace:

Library of Integrated Network-Based Cellular Signatures

Identifier Namespace (Entity type)

Granularity:

cell line

Subject Granularity (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Association Type:

not observed

Disease Association Type (Entity type)

Results found

Linked to

	Label	Description
	chronic myeloid leukemia Disease (Entity type)	A myeloid leukemia that is characterized by over production of white blood cells.
	Homo sapiens Taxonomy (Entity type)	man
	L1000 LINCS DCIC 2021 MOAR018 HAP1.PRKACA 24H B13 BMS-265246 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR013 HAP1.PRKACA 24H H13 PD-98059 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR016 HAP1.PRKACA 24H L14 erythromycin-ethylsuccinate 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR014 HAP1.PRKACA 24H L14 serdemetan 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR017 HAP1.PRKACA 24H D14 NVP-BEZ235 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR016 HAP1.PRKACA 24H K14 SJ-172550 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR017 HAP1.PRKACA 24H F14 LY-2835219 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR014 HAP1.PRKACA 24H G14 AS-601245 0.66uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

Disease

chronic myeloid leukemia

Disease (Entity type)

A myeloid leukemia that is characterized by over production of white blood cells.

Taxonomy

Homo sapiens

Taxonomy (Entity type)

man

L1000 LINCS DCIC 2021 MOAR018 HAP1.PRKACA 24H B13 BMS-265246 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR013 HAP1.PRKACA 24H H13 PD-98059 3.33uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR016 HAP1.PRKACA 24H L14 erythromycin-ethylsuccinate 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR014 HAP1.PRKACA 24H L14 serdemetan 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR017 HAP1.PRKACA 24H D14 NVP-BEZ235 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR016 HAP1.PRKACA 24H K14 SJ-172550 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR017 HAP1.PRKACA 24H F14 LY-2835219 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 MOAR014 HAP1.PRKACA 24H G14 AS-601245 0.66uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.